SCHEMBL24960733

SCHEMBL24960733

Oc1c(O)c(O)c(-c2ccc3c(-c4cccc5ccccc45)c4ccccc4c(-c4cccc5ccccc45)c3c2)c(O)c1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.44
▸ ACMSD Q8TDX5 1/20 0.44
▸ ALOX5 P09917 1/20 0.41
▸ SOS1 Q07889 1/20 0.40
▸ HDAC8 Q9BY41 2/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ HDAC4 P56524 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MPI P34949 1/20 0.39
▸ PSD A5PKW4 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ TLR8 Q9NR97 1/20 0.38
▸ CA12 O43570 2/20 0.37
▸ CA1 P00915 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26482166 0.94 MCL1 (0.43) MCL1ACMSDALOX5SOS1HDAC8
SCHEMBL26482177 0.93 HDAC4 (0.48) MCL1ACMSDALOX5SOS1HDAC8
SCHEMBL26482173 0.93 HDAC4 (0.48) MCL1ACMSDALOX5SOS1HDAC8
SCHEMBL26482175 0.93 MCL1 (0.43) MCL1ACMSDALOX5SOS1MEN1
SCHEMBL2955115 0.88 CA12 (0.45) MCL1ACMSDSOS1HDAC8HDAC6
SCHEMBL29770904 0.86 MCL1 (0.49) MCL1ACMSDSOS1HDAC8HDAC6
SCHEMBL22345775 0.86 MCL1 (0.49) MCL1ACMSDSOS1HDAC8HDAC6
SCHEMBL21710729 0.85 MCL1 (0.42) MCL1ACMSDALOX5SOS1HDAC8
SCHEMBL26482174 0.83 MCL1 (0.34) MCL1ACMSDALOX5SOS1MEN1
SCHEMBL24922893 0.83 CA12 (0.43) MCL1ACMSDALOX5SOS1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128708-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2023-04-27 — — US disclosed
US-20230128708-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2023-04-27 — — US disclosed
US-11569449-B2 Organic electroluminescence device and novel compound IDEMITSU KOSAN CO., LTD. (JP) 2023-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128708-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND PIEZO1, TMEM109, OXA1L MCL1 2105/4885ACMSD 910/4885ALOX5 4031/4885
US-11569449-B2 Organic electroluminescence device and novel compound PIEZO1, TMEM109, OXA1L MCL1 2105/4885ACMSD 910/4885ALOX5 4031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback